CELF1 and myotonic dystrophy type 1: The evaluation of the proteins of the GSK3β-CUGBP1 pathway in the blood of DM1 patients raised the question of whether the levels of active GSK3β in DM1 blood are comparable to those in other cells like skin fibroblasts.